Filing Flows › Definitive Healthcare (DH) › Guidance & outlook
Definitive Healthcare (DH) guidance and outlook
Definitive Healthcare's 10-Q filed Nov 5, 2026 makes 39 forward-looking statements.
Guidance and outlook
Forward-looking statements, 10-Q filed Nov 5, 2026
- We also offer claims and consumer analytics built from modeled data on millions of unique consumers to help healthcare organizations target, message, and engage specific healthcare audiences.
- In total, our target universe includes more than 100,000 potential customers that we believe could benefit from our products.
- No decisions have been made with respect to our response to the proposal or any alternatives thereto, and there can be no assurance that we will pursue the proposed transaction or any other strategic alternative, or that any transaction will be approved or consummated.
- In the first quarter of 2026, we committed to a restructuring plan (the “2026 Restructuring Plan”) intended to reduce operating costs, improve operating margins, and continue advancing the Company’s ongoing commitment to profitable growth.
- We expect these payments will be made in the fourth quarter of 2026.
- In addition, we do not expect to incur further material charges associated with the 2026 Restructuring Plan.
- These factors, in addition to the lower than historical renewal rates we observed through fiscal year 2025, have impacted, and we expect will continue to impact, our results in 2026.
- We launched an initial pilot with select strategic customers in the third quarter of 2026 and expect to make Turbo more broadly available later this year.
- The elevated churn has impacted our revenue growth since 2023, and we expect this will continue to have an impact on our growth in 2026.
- However, late in 2025 and through the first half of 2026, we have been seeing modest signs of improvement in the macroeconomic backdrop, with healthier demand trends, more normalized procurement cycles, improving customer retention dynamics, and increased visibility into customer budgets, all of which are encouraging signs we will continue to monitor.
- We plan to organically grow the number of customers that use our platform by increasing demand for our platform and penetrating our addressable market.
- We intend to drive new customer acquisition with our efficient go-to-market engine by continuing to invest in our sales and marketing efforts and developing new use cases for our platform.
Definitive Healthcare's latest quarter
Definitive Healthcare, Q3 2026: revenue $54.6M (-9% year over year), operating margin -9.1%, net loss $5.4M, operating cash flow $11.4M. The chart follows the revenue to costs, profit and cash.
Questions
What does Definitive Healthcare expect?
We also offer claims and consumer analytics built from modeled data on millions of unique consumers to help healthcare organizations target, message, and engage specific healthcare audiences. In total, our target universe includes more than 100,000 potential customers that we believe could benefit from our products. No decisions have been made with respect to our response to the proposal or any alternatives thereto, and there can be no assurance that we will pursue the proposed transaction or any other strategic alternative, or that any transaction will be approved or consummated.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.